Cancer Weekly articles from February 2002

Cancer Weekly archives from February 2002

Macrophages From Patients May Provide Ready Source Of Dendritic Cells.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Pulmonary immune cells from lung cancer patients can be induced to differentiate into dendritic cells (DCs), researchers in Japan report. Yoshihiro Suzuki...

Chemotherapies May Cause Impaired Fracture Healing In Cancer Patients.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Drugs commonly used in cancer therapy have enabled medical researchers to see how bone fracture healing can sometimes go awry, based on an investigation of...

First Consensus Opinion On Risk Management With Ductal Lavage Published.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Two oncologists at Baylor University Medical Center (BUMC), Dallas, Texas, published the first guidelines on the use of ductal lavage to help manage high-risk breast cancer. The guidelines were...

Pathway Links Dysplasia To Invasion In Laryngeal Squamous Cell Carcinoma.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A comprehensive analysis of head and neck cancers has linked the nitric oxide (NO) pathway with angiogenesis and progression in laryngeal squamous cell...

Study To Examine Tea, Diet Links To Cancer.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Cancer researcher Chung S. Yang and collaborators at Rutgers University will study tea and its potential to prevent cancer under a $5.7 million, 5-year program project grant from the National Cancer...

Diabetes, A Cofactor For Ischemic Stroke Risk Following Radiotherapy.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Physicians in the Netherlands have named head and neck cancer radiation therapy a significant risk factor for ischemic stroke in patients who receive treatment...

Arsenic Trioxide Works Through Caspase Pathway.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The antineoplastic agent arsenic trioxide uses the caspase pathway to induce apoptosis in leukemic cells, researchers in the United States and France report....

Sulforaphane's Protective Properties Beneficial Against Several Diseases.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Three recently published scientific studies reinforce the protective power of sulforaphane, the naturally occurring antioxidant in broccoli and broccoli sprouts, by demonstrating new aspects of disease...

Panacea Pharmaceuticals Adds to Clinical Advisory Board.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Panacea Pharmaceuticals, Inc., has appointed James K.V. Willson, MD, to its clinical advisory board. "I am excited by the prospects of Panacea's HAAH Oncology Program for both the diagnosis and...

TriPath Imaging Names New Head of Molecular Oncology Business Unit.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- TriPath Imaging, Inc., (TPTH) has appointed John G.R. Hurrell, PhD, as senior vice president, TriPath Oncology, Inc. Hurrell will oversee the general management of TriPath Oncology and TriPath's...

Anastrozole Receives FDA Fast-Track Designation For Early Disease.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced January 15, 2002, that the U.S. Food and Drug Administration (FDA) has granted Fast-Track Designation allowing for a rolling submission of data and expedited review of documents...

Detection Aided By New Technology.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Magee-Women's Hospital of University of Pittsburgh Medical Center (UPMC) Health System, Pennsylvania, has announced the availability of a promising new technology called computer-aided detection, or...

Imaging Diagnostic Patents Aspects of CT Laser Mammography System.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- The U.S. Patent and Trademark Office awarded Robert Wake and Richard Grable a patent for the "Detector Array With Variable Gain Amplifiers for Use in a Laser Imaging Apparatus," which was assigned to...

Positive Results From Proteomic Studies Reported.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- ProteEx, Inc., will present positive results of proteomic studies to develop high-resolution breast cancer diagnostics in collaboration with The University of Texas M.D. Anderson Cancer Center, at the...

Frost & Sullivan Hold Analyst Briefing.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Frost & Sullivan held a conference call on January 29, 2002, to provide manufacturers, end-users and other industry participants an overview, summary, challenges, and the latest coverage on...

DNA Vaccine Expressing Human Papillomavirus Gene Invites Viral Immunity.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - An experimental vaccine containing genes for the human papillomavirus 16-L1 (HPV16-L1) protein has shown promising results for halting tumor growth and...

Access Oncology and Gem Pharmaceuticals Sign Product Partnership.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Access Oncology's wholly owned pharmaceutical subsidiary has entered into a definitive license agreement with Gem Pharmaceuticals, Inc., for GPX-100 and GPX-150, two novel, noncardiotoxic analogs of...

Action Underway On Obesity In United Kingdom.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- United Kingdom Public Health Minister Yvette Cooper welcomed a report published recently by the Public Accounts Committee about obesity management. "There are clear links between obesity and our...

4SC and Wilex Collaborate to Optimize Second-Generation uPA Inhibitors.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- 4SC AG and Wilex AG have signed a research collaboration to optimize and synthesize second-generation inhibitors of urokinase (human urokinase-type plasminogen activator, uPA), a protein known to play a...

Genzyme Molecular Oncology Receives Patent Relating To SPHERE Technology.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology announced the issuance of U.S. Patent No. 6,338,945 ('945) relating to its high throughput screening technology known as SPHERE. The method described in the patent...

New Treatment Extends Life For Patients.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- A new treatment for a fatal form of lung cancer holds the promise of dramatic improvement in survival for many patients, said a Vanderbilt-Ingram Cancer Center physician. Dr. Alan Sandler, director...

Ifosfamide-Vinorelbine Regimens Effectively Mobilize Stem Cells For Transplant.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Chemotherapy regimens based on ifosfamide and vinorelbine can effectively mobilize hematopoietic stem cells for harvesting and autologous transplantation,...

Gene Screen Predicts Tumor Prognosis.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- A profiling system can be used to predict the clinical outcome of medulloblastoma, the most common type of childhood malignant brain tumor. Little is known about early childhood central nervous...

Cell Receptor May Absorb Chemicals That Lead To Metastasis.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- A specially designed cell receptor may reduce death rates from pancreatic and other cancers by sopping up excess tumor-produced chemicals like a sponge, a University of California-Irvine College of...

Impath to Acquire Tamtron Corp.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Impath, Inc., (IMPH) has signed an agreement to acquire Tamtron Corp., a provider of pathology information management software to hospitals and laboratories. The agreement is subject to certain...

Eos Biotechnology and ICOS Sign Manufacturing and Licensing Agreements.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- Eos Biotechnology, Inc., has signed a manufacturing and a licensing agreement with ICOS Corp. Under the terms of the manufacturing agreement ICOS will produce Eos' lead monoclonal antibody...

HLA Allele Mismatches Do Not Increase Graft Failure Risk.(Brief Article)
February 5, 2002... 2002 FEB 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hard-to-detect human leukocyte antigen (HLA) mismatches between stem cell donors and recipients may not have a negative effect on engraftment, researchers in...

CD34-Enriched Stem Cell Grafts Hasten Recovery After Myeloablative Chemotherapy.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hematopoietic stem cell grafts processed to minimize the number of CD34[superscript]- cells can improve recovery in advanced breast cancer patients undergoing...

Thymidine Kinase Gene Therapy Extends Survival In Recurrent Cancer.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A combination of tumor debulking, gene therapy, and drug therapy has been determined to increase survival in women with recurrent ovarian cancer approximately...

Signal Transduction Inhibitor 571 Has Little Effect On Most Malignant Cells.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Texas say that, contrary to previous reports, signal transduction inhibitor 571 (STI571) does not effectively prevent acute myelogenous leukemia...

Antisense Gene Therapy Overcomes Clusterin-Mediated Therapy Resistance.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists have been able to knock out resistance to chemotherapy in bladder cancer by using antisense gene therapy targeting clusterin expression. They...

'One-Two Punch' Hits Key Growth Signal Pathway.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Researchers at Vanderbilt University's Vanderbilt-Ingram Cancer Center have reported a successful "one-two punch" against breast cancer in cell and animal studies using two targeted therapies that...

Insulin Levels Associate With Worst Outcomes In Early Breast Cancer.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists have detected a link between insulin production and an excess risk for recurrence and death in women with early stage breast cancers. Their...

Pretreatment Microvessel Density Yields Prognosis In Esophageal Cancer.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - According to a new report, examining biopsy specimens from esophageal cancers before administering combination therapies could help doctors to predict...

High-Dose Melphalan Without Irradiation Best Option For Stem Cell Transplantation.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Total body irradiation (TBI) should not be part of the standard conditioning regimen for multiple myeloma patients undergoing autologous stem cell...

Different Ways Of Assessing Early Treatment Response Yield Discordant Results.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Different techniques for assessing the early response to chemotherapy in children with acute lymphoblastic leukemia (ALL) can produce results that are at odds...

Researchers Tailor Cancer Cells' Sugar Jackets To Inhibit Tumor Growth.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Massachusetts Institute of Technology (MIT) scientists wielding molecular scissors have shown for the first time that the sugar jackets of cancer cells can be tailored to inhibit tumors. The work,...

Tumor-Modifier Gene Search Will Have Potentially Important Applications.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Studies on genetic resistance to certain types of cancer in rats are helping University of Toronto researchers learn more about cancer resistance in humans, according to an article in the January 2002...

Oltipraz An Antiangiogenic Agent That Could Treat Advanced Stage Cancers.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Oltipraz, a drug that has been used for treating schistosomiasis, a parasitic disease, has shown effectiveness as an antiangiogenic agent in laboratory and...

Safe, Reliable Stool Test Detects Early Stages of Disease.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Scientists at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University have developed a safe and reliable stool test that can detect the earliest, curable stages of colon cancer. ...

Clinical Trial Tests Gel For Treatment Of Precursor To Skin Cancer.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Researchers at Fox Chase Cancer Center, Philadelphia, Pennsylvania, are conducting an innovative clinical trial using bexarotene (Targretin), a form of vitamin A in a topical gel, to treat...

Marijuana-Derived Drug Less Effective Than Standard For Improving Appetite, Weight In Patients With Advanced Cancer.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- A drug derived from marijuana is not as effective as a standard drug for curbing loss of appetite and weight in patients with advanced cancer, according to a study conducted by Mayo Clinic in...

Protein May Be Target For New Cancer Drugs.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- During development of multicellular organisms, cells are bombarded by signals from their environment. The repertoire of receptors that cells display on their surfaces often determines whether or not...

New CAD System Launched To Aid Breast Cancer Diagnosis.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Instrumentarium Imaging announced the clearance by the FDA of the ISSI MammoReader CAD system. The MammoReader was developed by Intelligent Systems Software, Inc., and is distributed exclusively in...

Transgene Initiates Two Phase II Trials In Breast, Lung Cancer.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Transgene (TRGNY, TRANSGENE) has initiated two Phase II clinical trials of its immunotherapeutic MVA-Muc1-IL2 vaccine candidate, one for the treatment of lung cancer, the second for the treatment of...

Court of Appeals Confirms Ruling That Generic Taxol Approval Should Be Withdrawn.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- The Federal Court of Appeals for the District of Columbia confirmed that Ivax Corp.'s approval to market a generic version of Taxol should be withdrawn. In a ruling issued on January 11, the court let...

Enrollment Completed in LY900003 Trial.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Enrollment has been completed in a late-phase clinical trial of LY900003 (ISIS 3521) in patients with non-small cell lung cancer, which affects more than 1 million people worldwide. LY900003 (ISIS...

Patients With Advanced Disease Show Encouraging Survival Rates With Onconase.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Alfacell Corp. (ACEL) has published Phase II trial results of Onconase, a novel anticancer drug, in patients with unresectable, or inoperable, malignant mesothelioma (MM), an asbestos-related cancer of...

Prediction of Childhood Brain Tumor Outcomes Improved with Gene Expression Profile.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- A distinctive "signature" of genes turned on and off greatly improves predictions of who has the best chance of survival of the most common type of childhood malignant brain tumor, according to a new...

Histamine-IL-2 Combo Improves Survival For Patients With Advanced Disease.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Results from a study published in the Journal of Clinical Oncology confirm that a combination therapy for patients with advanced melanoma improves survival without increasing the negative side effects...

Human Genome Sciences Files IND Application For Lymphorad(131).(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for LymphoRad(131), a radioiodinated form of B Lymphocyte...

Quercetin, Vitamin C Anticarcinogenic Activities Elucidated.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Scientists from Cornell University in New York and Seoul National University in South Korea are offering a more precise explanation for vitamin C's anticancer activity. And they suggest that a natural...

Capecitabine Shows Potential for Metastatic Disease.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Data published by a Florida physician affiliated with U.S. Oncology, Inc., (USON) in a January issue of the Journal of Clinical Oncology reveal that the oral chemotherapy Xeloda (capecitabine),...

U.K. Offers Network to Improve Patient Access to Experimental Treatments.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Cancer patients in the United Kingdom will benefit from better access to new and experimental treatments, thanks to a new government-funded network of cancer research centers, according to Public...

Plant Extract Found To Kill Melanoma Tumors.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- Credere Corp. of Southern California has announced a significant breakthrough in ongoing research into the treatment of melanoma with the use of the company's patented, purified plant compound, LP-9....

Tripath Imaging Signs Agreement With Dynacare.(Brief Article)
February 12, 2002... 2002 FEB 12 - (NewsRx.com & NewsRx.net) -- TriPath Imaging, Inc., (TPTH) has entered into an agreement with Dynacare, Inc., (DNCR; DNA) to provide liquid-based, thin-layer preparation technology for gynecologic and nongynecologic cytology and...

Neovastat Prevents Bone Destruction In Metastatic Cancers.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A newly developed agent now being investigated in Canada might be useful for preventing bone destruction caused by metastatic cancer cells. Scientists at...

Inadvertent Angiostatin Removal During Surgery Produces Liver Lesions.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The same surgery meant for treating patients with uveal melanoma could actually precipitate their forming liver metastases. Enucleation, the removal of...

Cytokine Immunizations Work Better When Local Tumor Irradiation Included.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Cell factor vaccines that can prevent the growth of gliomas work better when the tumors are also treated with local radiotherapy, medical researchers in...

Some Melanoma Cells Form New Blood Vessels In Vessel-Damaged Tissue.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Cancer researchers at the University of Iowa and Loyola University in Chicago have demonstrated that aggressive human melanoma cells form new blood vessels when placed in living tissue that is in need...

Variability Of Gene Expression Observed In Hepatocellular Carcinoma.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - An Israeli study indicates that contrary to previous reports, there appears to be a great degree of differential gene expression in hepatocellular carcinoma,...

Ovarian Cancer-Specific Promoter Sensitizes Tumors To Cancer Drug.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Plasmid vectors expressing an ovarian cancer-specific promoter do a better job of directing gene therapy to ovarian tumors than some other vectors do,...

Microenvironment, Ras Protein Combine To Increase Malignant Formation.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Oncoproteins work in concert with the tumor microenvironment to increase tumor angiogenesis and invasion, researchers in Germany say. "The genetic...

Nighttime Heartburn Is Keeping Greensboro Awake.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Of the nearly 350,000 people in the Greensboro area who suffer from heartburn, more than 65% report experiencing nighttime heartburn, a painful and serious health concern, according to a survey by the...

Thalidomide Causes Temporary Regression In Leukemia Patients.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Physicians in Germany have reported that the drug thalidomide might be beneficial for treating some patients diagnosed with acute myeloid leukemia. In...

Bill Gannon Hired As Clinical Affairs Director.(Celsion Corp. appoints William E. Gannon, Jr. vice president)
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Celsion Corp. (CLN) announced the appointment of William ("Bill") E. Gannon Jr., MD as vice president, clinical affairs, medical director. In addition to medical training and clinical work at Case...

Researcher: Mammography Saves Lives.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- A team from Cornell Medical Center has taken a fresh look at data that caused some investigators to doubt that mammography saves lives, and has concluded that there is a significant benefit over the...

Companies Will Develop Cell-Based Therapies.(Schering AG and Mologen)
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Schering AG of Berlin and Mologen, a biotechnology corporation also located in Berlin, Germany, signed a contract to develop cell-based therapies by using Mologen's MIDGE technology. Among the...

Phase II Clinical Trials Initiated With Immunotherapeutic For Lung and Breast Cancers.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Transgene (TRGNY; TRANSGENE) announced the initiation of two Phase II clinical trials of its immunotherapeutic MVA-Muc1-IL2 vaccine candidate: one for the treatment of lung cancer, the second for the...

Groups Launch PSAs To Promote Early Detection.(the Advertising Council and the American Cancer Society begin public service announcements to promote early colon cancer detection)
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- The Advertising Council and the American Cancer Society announced the launch of a national public service advertising (PSA) campaign that uses humor to encourage people to get tested for colon cancer....

Merck KGaA's European Development Plan For C225 Remains Unchanged.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Merck KGaA confirmed that its European studies for the cancer treatment C225 (cetuximab, Erbitux) are continuing as planned. Merck has a license to the rights for C225 outside of North America,...

VA Compensates More Veterans Exposed To Radiation.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Secretary of Veterans Affairs (VA) Anthony J. Principi announced the addition of five new cancers to the list of diseases presumed to be connected to the exposure of veterans to radiation during their...

State to Analyze Cluster of Cancer Cases.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- New Hampshire health officials are studying whether more than two dozen cancer cases in Atkinson are related. Debra DeSimone began talking with her neighbors after both she and her daughter were...

Belgian Toxic Food Scare Spreads to Pork.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- The country's latest toxic food scare spread beyond poultry into the pork industry after authorities admitted some pigs that had eaten contaminated feed had already entered the food supply. ...

Aerosolized Gene Therapy Puts Damper On Angiogenesis In Lung Metastases.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Baylor College of Medicine researchers in Houston, Texas, have developed a method for delivering gene therapy to the lungs using an aerosolized polymer. They...

Survival Data For Ribonuclease Anticancer Drug Are Encouraging.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Alfacell Corporation (ACEL) announced the publication of Phase II trial results of Onconase (ranpirnase), a novel anticancer drug, in patients with unresectable, or inoperable, malignant mesothelioma...

Vaccine Combination Rejects Brain Tumor Establishment In Rodents.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using a combination of cytokine-based gene therapy and tumor cell vaccination, medical investigators have been able to produce immunity against brain tumors in...

AltaRex Announces Positive OvaRex Phase IIb Results.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO.TO) has announced positive clinical results from a primary analysis of its 345-patient OvaRex combined U.S. and Canadian Phase IIb trial in metastatic late stage ovarian cancer....

Report Evaluates Emerging Therapies.(Decision Resources Inc. reports on pancreatic cancer therapies)
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., announces the publication of "Pancreatic Cancer," a new study that evaluates the current status of, and future prospects for, therapies to treat this highly virulent cancer....

Researchers Challenge Value of Widely Used Diagnostic Methods.(for prostate cancer)
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- Serendipity rather than science plays a prominent role in the current diagnosis of prostate cancer, according to Stanford University Medical Center researchers. A new study finds that prostate...

ViaCirq Announces Results Of Study Using Intraperitoneal Hyperthermia.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- ViaCirq, a subsidiary of BICO, Inc., (BIKO) has sponsored the first and only long-term quality of life study with Wake Forest University Baptist Medical Center involving patients who have survived...

Computerized Tool Predicts Outcome, Potentially Improves Treatment Decisions.
February 26, 2002... 2002 FEB 19 - (NewsRx.com & NewsRx.net) -- In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan-Kettering Cancer Center say they have developed a new prognostic tool that is...